Follow
Sreyashi Basu
Sreyashi Basu
Verified email at mdanderson.org
Title
Cited by
Cited by
Year
Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway
S Basu, RJ Binder, R Suto, KM Anderson, PK Srivastava
International immunology 12 (11), 1539-1546, 2000
17362000
CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin
S Basu, RJ Binder, T Ramalingam, PK Srivastava
Immunity 14 (3), 303-313, 2001
14772001
Heat shock protein–peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity
NE Blachere, Z Li, RY Chandawarkar, R Suto, NS Jaikaria, S Basu, ...
The Journal of experimental medicine 186 (8), 1315-1322, 1997
8051997
Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world
PK Srivastava, A Menoret, S Basu, RJ Binder, KL McQuade
Immunity 8 (6), 657-665, 1998
7731998
Efficacy, safety, and biomarkers of response to azacitidine and nivolumab in relapsed/refractory acute myeloid leukemia: a nonrandomized, open-label, phase II study
N Daver, G Garcia-Manero, S Basu, PC Boddu, M Alfayez, JE Cortes, ...
Cancer discovery 9 (3), 370-383, 2019
4492019
Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells
S Somersan, M Larsson, JF Fonteneau, S Basu, P Srivastava, N Bhardwaj
The journal of immunology 167 (9), 4844-4852, 2001
3882001
Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor-and peptide-specific immunity
S Basu, PK Srivastava
The Journal of experimental medicine 189 (5), 797-802, 1999
3551999
Ipilimumab with stereotactic ablative radiation therapy: phase I results and immunologic correlates from peripheral T cells
C Tang, JW Welsh, P De Groot, E Massarelli, JY Chang, KR Hess, S Basu, ...
Clinical Cancer Research 23 (6), 1388-1396, 2017
2982017
Cutting edge: heat shock protein gp96 induces maturation and migration of CD11c+ cells in vivo
RJ Binder, KM Anderson, S Basu, PK Srivastava
The Journal of Immunology 165 (11), 6029-6035, 2000
2922000
Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer
J Blando, A Sharma, MG Higa, H Zhao, L Vence, SS Yadav, J Kim, ...
Proceedings of the National Academy of Sciences 116 (5), 1692-1697, 2019
2872019
Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma
S Goswami, T Walle, AE Cornish, S Basu, S Anandhan, I Fernandez, ...
Nature medicine 26 (1), 39-46, 2020
2682020
The distribution of T‐cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia
P Williams, S Basu, G Garcia‐Manero, CS Hourigan, KA Oetjen, ...
Cancer 125 (9), 1470-1481, 2019
2562019
Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma
J Gao, N Navai, O Alhalabi, A Siefker-Radtke, MT Campbell, RS Tidwell, ...
Nature medicine 26 (12), 1845-1851, 2020
2162020
Heat shock proteins: the fountainhead of innate and adaptive immune responses
S Basu, PK Srivastava
Cell stress & chaperones 5 (5), 443, 2000
1932000
Immunological role of neuronal receptor vanilloid receptor 1 expressed on dendritic cells
S Basu, P Srivastava
Proceedings of the National Academy of Sciences 102 (14), 5120-5125, 2005
1772005
Endocannabinoid system acts as a regulator of immune homeostasis in the gut
N Acharya, S Penukonda, T Shcheglova, AT Hagymasi, S Basu, ...
Proceedings of the National Academy of Sciences 114 (19), 5005-5010, 2017
1512017
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial
AO Kaseb, E Hasanov, HST Cao, L Xiao, JN Vauthey, SS Lee, BG Yavuz, ...
The Lancet Gastroenterology & Hepatology 7 (3), 208-218, 2022
1292022
Fever‐like temperature induces maturation of dendritic cells through induction of hsp90
S Basu, PK Srivastava
International immunology 15 (9), 1053-1061, 2003
1222003
Idarubicin, cytarabine, and nivolumab in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a single-arm, phase 2 study
F Ravandi, R Assi, N Daver, CB Benton, T Kadia, PA Thompson, ...
The Lancet Haematology 6 (9), e480-e488, 2019
1192019
Immunotherapy of tumors with neuroimmune ligand capsaicin
J Beltran, AK Ghosh, S Basu
The Journal of Immunology 178 (5), 3260-3264, 2007
902007
The system can't perform the operation now. Try again later.
Articles 1–20